BRPI0911426A2 - ferramentas terapêuticas e métodos para tratar cegueira - Google Patents

ferramentas terapêuticas e métodos para tratar cegueira

Info

Publication number
BRPI0911426A2
BRPI0911426A2 BRPI0911426A BRPI0911426A BRPI0911426A2 BR PI0911426 A2 BRPI0911426 A2 BR PI0911426A2 BR PI0911426 A BRPI0911426 A BR PI0911426A BR PI0911426 A BRPI0911426 A BR PI0911426A BR PI0911426 A2 BRPI0911426 A2 BR PI0911426A2
Authority
BR
Brazil
Prior art keywords
methods
therapeutic tools
treat blindness
blindness
treat
Prior art date
Application number
BRPI0911426A
Other languages
English (en)
Inventor
Botond Roska
David Balya
Pamela Lagali
Volker Busskamp
Original Assignee
Novartis Forschungsstiftung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Forschungsstiftung filed Critical Novartis Forschungsstiftung
Publication of BRPI0911426A2 publication Critical patent/BRPI0911426A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/215—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Halobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/025—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a parvovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0911426A 2008-04-18 2009-04-16 ferramentas terapêuticas e métodos para tratar cegueira BRPI0911426A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08154828 2008-04-18
EP08155942 2008-05-09
PCT/EP2009/054562 WO2009127705A1 (en) 2008-04-18 2009-04-16 Novel therapeutical tools and methods for treating blindness

Publications (1)

Publication Number Publication Date
BRPI0911426A2 true BRPI0911426A2 (pt) 2015-09-29

Family

ID=40626866

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911426A BRPI0911426A2 (pt) 2008-04-18 2009-04-16 ferramentas terapêuticas e métodos para tratar cegueira

Country Status (14)

Country Link
US (4) US20120258530A1 (pt)
EP (2) EP2271369B1 (pt)
JP (2) JP2011516091A (pt)
KR (1) KR20100136550A (pt)
CN (1) CN101970013B (pt)
AU (1) AU2009237585C1 (pt)
BR (1) BRPI0911426A2 (pt)
CA (1) CA2721635A1 (pt)
EA (1) EA201001621A1 (pt)
ES (1) ES2474721T3 (pt)
MX (1) MX2010011467A (pt)
PL (1) PL2271369T3 (pt)
PT (1) PT2271369E (pt)
WO (1) WO2009127705A1 (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101970013B (zh) 2008-04-18 2014-11-05 诺瓦提斯研究基金会弗里德里克·米谢尔生物医学研究所 治疗失明的新型治疗工具和方法
EP2315833B8 (en) 2008-05-20 2015-05-27 Eos Neuroscience, Inc. Vectors for delivery of light-sensitive proteins and methods of use
WO2011039161A1 (en) * 2009-09-29 2011-04-07 Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute For Biomedical Research Functionalized organotypic systems
US9545422B2 (en) * 2010-03-01 2017-01-17 The Regents Of The University Of California Methods of inducing photosensitivity by targeting channelrhodopsin-2 and halorhodopsin to subcellular regions of retinal ganglion cells
WO2011127088A2 (en) 2010-04-05 2011-10-13 Eos Neuroscience, Inc. Methods and compositions for decreasing chronic pain
EP2383286A1 (en) 2010-04-30 2011-11-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treatment of retinal degenerative diseases
US20140099284A1 (en) 2010-10-15 2014-04-10 Eos Neuroscience, Inc Modulation neural pathways
US8868351B2 (en) 2011-10-13 2014-10-21 The Cleveland Clinic Foundation Estimation of neural response for optical stimulation
KR102194185B1 (ko) * 2011-11-12 2020-12-22 메사추세츠 인스티튜트 오브 테크놀로지 세포의 광학 조절을 위한 채널로돕신
US20150038557A1 (en) * 2012-02-24 2015-02-05 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and compositions for treatment of retinal degenerative diseases
EP2888368A1 (en) 2012-08-27 2015-07-01 Friedrich Miescher Institute for Biomedical Research Retinal off circuit-specific promoter
EP3007730A1 (en) * 2013-06-11 2016-04-20 Friedrich Miescher Institute for Biomedical Research Retinal on bipolar cells-specific artificial promoter
JP2017501834A (ja) * 2014-01-08 2017-01-19 サーキット セラピューティクス， インコーポレイテッド 高眼圧症の治療管理のための方法
GB201403260D0 (en) * 2014-02-25 2014-04-09 Univ Manchester Treatment of retinal degeneration using gene therapy
GB201503008D0 (en) * 2015-02-23 2015-04-08 Ucl Business Plc Treatment
WO2016174624A1 (en) 2015-04-30 2016-11-03 Friedrich Miescher Institute For Biomedical Research Promoter for the specific expression of genes in müller cells
JP6898920B2 (ja) * 2015-09-15 2021-07-07 フリードリッヒ ミーシェー インスティトゥート フォー バイオメディカル リサーチ 光受容器のターゲッティングにより失明を治療するための新規な治療用ツールおよび方法
EP3362101B1 (en) 2015-10-14 2021-05-19 Friedrich Miescher Institute for Biomedical Research Promoter for the specific expression of genes in retinal endothelial cells
ES2909444T3 (es) 2015-12-03 2022-05-06 Friedrich Miescher Institute For Biomedical Res Synp159, un promotor para la expresión específica de genes en los fotorreceptores de los bastones
CN108474001B (zh) * 2015-12-03 2022-04-08 弗里德里克·米谢尔生物医学研究所 SynP160，用于基因在视杆光感受器中特异性表达的启动子
EP3383440B1 (en) 2015-12-03 2021-06-30 Friedrich Miescher Institute for Biomedical Research Synp162, a promoter for the specific expression of genes in rod photoreceptors
CA3006952A1 (en) 2015-12-03 2017-06-08 Friedrich Miescher Institute For Biomedical Research Synp161, a promoter for the specific expression of genes in rod photoreceptors
CA3025975A1 (en) 2016-04-29 2017-11-02 Gensight Biologics Sa Optogenetic visual restoration using chrimson
US20190218256A1 (en) * 2016-06-03 2019-07-18 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Mutant light-inducible ion channel of channelrhodopsin
CA3037436A1 (en) * 2016-09-22 2018-03-29 Sorbonne Universite Optogenetically transformed photoreceptor precursor cells for the use in the treatment of retinal degenerative diseases
AU2017354086C1 (en) * 2016-11-02 2021-05-06 Friedrich Miescher Institute For Biomedical Research SynP198, a promoter for the specific expression of genes in direction selective retinal ganglion cells
WO2018099975A1 (en) * 2016-12-01 2018-06-07 Friedrich Miescher Institute For Biomedical Research Synpi, a promoter for the specific expression of genes in interneurons
CN110392582A (zh) 2017-02-08 2019-10-29 弗里德里克·米谢尔生物医学研究所 用于使基因在视网膜神经节细胞中特异性表达的启动子SynP88
EP3609518A1 (en) * 2017-04-12 2020-02-19 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. New optogenetic tool
EP3422065A1 (en) 2017-06-28 2019-01-02 Gensight Biologics Objective, camera and system adapted for optogenetics comprising such objective
AU2018369975B2 (en) 2017-11-15 2022-05-19 Friedrich Miescher Institute For Biomedical Research Primate retinal pigment epithelium cell-specific promoter
KR20200091432A (ko) 2017-11-30 2020-07-30 프리드리히 미셔 인스티튜트 포 바이오메디칼 리서치 망막 색소 상피에서의 유전자의 특이적 발현을 위한 프로모터 SynPIII
ES2954941T3 (es) 2018-01-11 2023-11-27 Gensight Biologics Procedimiento y dispositivo para el procesamiento de señales asíncronas generadas por un sensor de luz basado en eventos
EP3693060A1 (en) 2019-02-05 2020-08-12 Gensight Biologics Method for controlling an optogenetic device using a command law for the radiant power of a light source and associated devices
EP3693061A1 (en) 2019-02-05 2020-08-12 Gensight Biologics Method for controlling an optogenetic device using filtering and associated devices
EP3733139A1 (en) 2019-05-02 2020-11-04 Gensight Biologics Viewing apparatus and method for projecting a light signal
GB202002073D0 (en) * 2020-02-14 2020-04-01 Ucl Business Ltd Horizontal cells

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002322277A1 (en) * 2001-06-21 2003-01-08 Curagen Corporation Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
WO2003014703A2 (en) * 2001-08-09 2003-02-20 Curagen Corporation Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
DE10216005A1 (de) 2002-04-11 2003-10-30 Max Planck Gesellschaft Verwendung von biologischen Photorezeptoren als direkt lichtgesteuerte Ionenkanäle
WO2007131180A2 (en) * 2006-05-04 2007-11-15 Wayne State University Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids
EP1891976A1 (en) * 2006-08-23 2008-02-27 Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute for Biomedical Research Use of light sensitive genes
US20090011040A1 (en) * 2007-05-02 2009-01-08 Naash Muna I Use of compacted nucleic acid nanoparticles in non-viral treatments of ocular diseases
CN101970013B (zh) 2008-04-18 2014-11-05 诺瓦提斯研究基金会弗里德里克·米谢尔生物医学研究所 治疗失明的新型治疗工具和方法
EP2888368A1 (en) 2012-08-27 2015-07-01 Friedrich Miescher Institute for Biomedical Research Retinal off circuit-specific promoter
WO2015118507A1 (en) 2014-02-10 2015-08-13 Friedrich Miescher Institute For Biomedical Research Aii retinal amacrine cell-specific promoter
ES2748282T3 (es) 2014-02-11 2020-03-16 Friedrich Miescher Institute For Biomedical Res Promotor específico de células de Müller
WO2016174624A1 (en) 2015-04-30 2016-11-03 Friedrich Miescher Institute For Biomedical Research Promoter for the specific expression of genes in müller cells
JP6898920B2 (ja) 2015-09-15 2021-07-07 フリードリッヒ ミーシェー インスティトゥート フォー バイオメディカル リサーチ 光受容器のターゲッティングにより失明を治療するための新規な治療用ツールおよび方法
EP3362101B1 (en) 2015-10-14 2021-05-19 Friedrich Miescher Institute for Biomedical Research Promoter for the specific expression of genes in retinal endothelial cells
EP3383440B1 (en) 2015-12-03 2021-06-30 Friedrich Miescher Institute for Biomedical Research Synp162, a promoter for the specific expression of genes in rod photoreceptors
CN108474001B (zh) 2015-12-03 2022-04-08 弗里德里克·米谢尔生物医学研究所 SynP160，用于基因在视杆光感受器中特异性表达的启动子
CA3006952A1 (en) 2015-12-03 2017-06-08 Friedrich Miescher Institute For Biomedical Research Synp161, a promoter for the specific expression of genes in rod photoreceptors
ES2909444T3 (es) 2015-12-03 2022-05-06 Friedrich Miescher Institute For Biomedical Res Synp159, un promotor para la expresión específica de genes en los fotorreceptores de los bastones
EP3384036B1 (en) 2015-12-04 2021-02-24 Sorbonne Université Promoters and uses thereof
US20190209708A1 (en) 2016-05-17 2019-07-11 Friedrich Miescher Institute For Biomedical Research Novel therapeutic tools and methods for treating blindness
AU2017354086C1 (en) 2016-11-02 2021-05-06 Friedrich Miescher Institute For Biomedical Research SynP198, a promoter for the specific expression of genes in direction selective retinal ganglion cells
WO2018099975A1 (en) 2016-12-01 2018-06-07 Friedrich Miescher Institute For Biomedical Research Synpi, a promoter for the specific expression of genes in interneurons
WO2018099974A1 (en) 2016-12-01 2018-06-07 Friedrich Miescher Institute For Biomedical Research Synp107, a promoter for the specific expression of genes in interneurons
CN110392582A (zh) 2017-02-08 2019-10-29 弗里德里克·米谢尔生物医学研究所 用于使基因在视网膜神经节细胞中特异性表达的启动子SynP88
AU2018369975B2 (en) 2017-11-15 2022-05-19 Friedrich Miescher Institute For Biomedical Research Primate retinal pigment epithelium cell-specific promoter
CR20200235A (es) 2017-11-30 2020-10-19 Friedrich Miescher Institute For Biomedical Res Synp61, un promotor específico de células del epitelio pigmentario retiniano de primates
KR20200091432A (ko) 2017-11-30 2020-07-30 프리드리히 미셔 인스티튜트 포 바이오메디칼 리서치 망막 색소 상피에서의 유전자의 특이적 발현을 위한 프로모터 SynPIII
JP2022512780A (ja) 2018-10-25 2022-02-07 フリードリッヒ ミーシェー インスティトゥート フォー バイオメディカル リサーチ 網膜神経節細胞中の遺伝子の特異的発現のためのプロモーターＳｙｎＰ１９４（ＰｒｏＢ１５）
EP3870709A1 (en) 2018-10-25 2021-09-01 Friedrich Miescher Institute for Biomedical Research Synp27 (prob12), a promoter for the specific expression of genes in protoplasmic astrocytes
US20210388386A1 (en) 2018-10-25 2021-12-16 Friedrich Miescher Institute For Biomedical Research Synp57 (proa14), a promoter for the specific expression of genes in photoreceptors
EP3870242A1 (en) 2018-10-25 2021-09-01 Friedrich Miescher Institute for Biomedical Research Synp151 (proc29), a promoter for the specific expression of genes in retinal ganglion cells
US20210355505A1 (en) 2018-10-25 2021-11-18 Friedrich Miescher Institute For Biomedical Research Synp78 (proa27), a promoter for the specific expression of genes in retinal ganglion cells
JP2022505516A (ja) 2018-10-25 2022-01-14 フリードリッヒ ミーシェー インスティトゥート フォー バイオメディカル リサーチ 網膜神経節細胞中の遺伝子の特異的発現のためのプロモーターＳｙｎＰ１７（ＰｒｏＢ１）

Also Published As

Publication number Publication date
EP2679246A3 (en) 2014-02-26
CA2721635A1 (en) 2009-10-22
US9844579B2 (en) 2017-12-19
EP2271369B1 (en) 2014-03-26
KR20100136550A (ko) 2010-12-28
US20160250282A1 (en) 2016-09-01
CN101970013A (zh) 2011-02-09
AU2009237585A1 (en) 2009-10-22
US20130059374A1 (en) 2013-03-07
US20180125925A1 (en) 2018-05-10
PL2271369T3 (pl) 2014-09-30
JP2015128440A (ja) 2015-07-16
AU2009237585C1 (en) 2013-09-26
MX2010011467A (es) 2011-02-15
WO2009127705A1 (en) 2009-10-22
AU2009237585B2 (en) 2013-03-14
EA201001621A1 (ru) 2011-06-30
PT2271369E (pt) 2014-07-10
US10987404B2 (en) 2021-04-27
ES2474721T3 (es) 2014-07-09
EP2271369A1 (en) 2011-01-12
JP2011516091A (ja) 2011-05-26
EP2679246A2 (en) 2014-01-01
US20120258530A1 (en) 2012-10-11
CN101970013B (zh) 2014-11-05

Similar Documents

Publication Publication Date Title
BRPI0914614A2 (pt) 2-arilaminoquinazolinas para tratar doenças proliferativas
SMT201600050B (it) Mezzi e metodi per trattare il dlbcl
BR212013028314U2 (pt) método para tratar câncer e dor de câncer de osso
BR112013018469A2 (pt) dispositivos e métodos para tratamento de tecidos
BRPI0915476A2 (pt) dispositivo para tratar problemas respiratórios
BR112013007678A2 (pt) método para tratamento de doenças alérgicas
BRPI0921321A2 (pt) métodos para o tratamento de indwcções e tumores
PT2271369E (pt) Novas ferramentas terapêuticas e métodos para tratar a cegueira
CY2014006I2 (el) Μεθοδοι θεραπευτικης αγωγης χρησιμοποιωντας γλυκοπεγκυλιωμενο g-csf
BRPI0907257A8 (pt) sistemas e métodos para estimulação elétrica terapêutica
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
BR112012002269A2 (pt) implemento para tratar superfície
BRPI1015233A2 (pt) métodos para tratar ou prevenir a fadiga
HRP20160551T8 (hr) Kombinirana terapija s pripravcima nanočestica taksana i hedgehog inhibitora
BRPI0919920A2 (pt) compostos para tratamento de doenças e desordens oftálmicas
BRPI0913574A2 (pt) composição de tratamento de acne compreendendo nanoprata e usos
PT2340042E (pt) Métodos e composições para o tratamento de cancro
BRPI0919127A2 (pt) métodos para tratamento de água
BRPI1011226A2 (pt) métodos para tratar condições relacionadas ao cabelo
BRPI0812755A2 (pt) Compostos de derivados de fenil alquinila para tratar doenças, e desordens oftálmicas
BRPI0822349A2 (pt) composições e métodos para tratar doenças lisossômicas
BRPI1013361A2 (pt) método para evitar e tratar hipermeabilidade.
BRPI0810091A2 (pt) Agentes fugicidas tópicos para tratar distúrbios ungueais
BRPI0917684A2 (pt) método terapêutico homeopático
BRPI1013509A2 (pt) método e composição para melhorar a absorção de agentes terapêuticos

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)